Stock listing

BOATS:RIGL Rigel Pharmaceuticals, Inc. Stock

US listing (BOATS) of Rigel Pharmaceuticals, Inc. · home listing NASDAQ:RIGL

Follow Rigel Pharmaceuticals, Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:RIGL

$45.97 USD -1.28 (-2.7%)

Close on Oct 16, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:RIGL

Since Jul 6, 2026 +14.2% · daily closes, Jul 6, 2026 – Oct 16, 2026, adjusted for splits
Day range
$45.68 – $47.58 USDOct 16, 2026
Volume
141,431 sharesOct 16, 2026
Market value
$858.7M USDAt the close on Oct 16, 2026 · price × 18.68M shares outstanding
Rigel Pharmaceuticals, Inc. logo
Ticker
BOATS:RIGL
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
BOATS
Currency
USD

What changed lately

Calls

Replays

  • Rigel Pharmaceuticals (NASDAQ:RIGL) Q2 2026 Earnings Call

    Tue, Aug 04, 2026 · 4:30 PM ET

    Watch Transcript
  • Rigel Pharmaceuticals (NASDAQ:RIGL) Q1 2026 Earnings Call

    Tue, May 05, 2026 · 4:30 PM ET

    Watch Transcript
  • Rigel Pharmaceuticals (NASDAQ:RIGL) Q4 2025 Earnings Call

    Tue, Mar 03, 2026 · 4:30 PM ET

    Watch Transcript

Latest news

All Rigel Pharmaceuticals, Inc. news

Decks

Rigel Pharmaceuticals, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
24 in the last 12 months · 139 in all · newest Oct 2, 2026 · oldest 2019
Calls
20 calls with a replay · 20 with a transcript · latest Aug 4, 2026
Decks
15 decks · latest Sep 15, 2026

Where Rigel Pharmaceuticals, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:RIGL · Home listingNASDAQUnited StatesUSD
LS Exchange:A40EFYLS ExchangeGermanyEUR
Lang & Schwarz:A40EFYLang & SchwarzGermanyEUR
gettex:RI2gettexGermanyEUR
Tradegate:RI2TradegateGermanyEUR
BX Swiss:RIGLBX SwissSwitzerlandCHF
BOATS:RIGL · This pageBOATSUnited StatesUSD
Dusseldorf:RI2DusseldorfGermanyEUR
Frankfurt:RI2FrankfurtGermanyEUR
Munich:RI2MunichGermanyEUR
Stuttgart:RI2StuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Rigel Pharmaceuticals, Inc.